BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 150227)

  • 1. Rosette-formation with mouse erythrocytes: VI. T, B, and third population lymphoid cells in mycosis fungoides and effect of leukopheresis.
    Gupta S; Safai B; Good RA
    Am J Hematol; 1978; 4(2):133-40. PubMed ID: 150227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome.
    Burg G; Rodt H; Grosse-Wilde H; Braun-Falco O
    J Invest Dermatol; 1978 May; 70(5):257-9. PubMed ID: 147911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T and B cells and cell-mediated immunity in mycosis fungoides.
    Nordqvist BC; Kinney JP
    Cancer; 1976 Feb; 37(2):714-8. PubMed ID: 130203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sézary syndrome lymphoid cell: abnormal surface properties and mitogen responsiveness.
    Braylan R; Variakojis D; Yachnin S
    Br J Haematol; 1975 Dec; 31(4):553-64. PubMed ID: 147100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current problems in mycosis fungoides and Sézary syndrome.
    Winkelmann RK; Caro WA
    Annu Rev Med; 1977; 28():251-69. PubMed ID: 140621
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC; Flandrin G
    Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes.
    Gupta S; Good RA; Siegal FP
    Clin Exp Immunol; 1976 Aug; 25(2):319-27. PubMed ID: 1085238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural, immunologic, and functional studies on Sézary cells: a neoplastic variant of thymus-derived (T) lymphocytes.
    Zucker-Franklin D; Melton JW; Quagliata F
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1877-81. PubMed ID: 4275944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosette formation with mouse erythrocytes. III. Studies in patients with primary immunodeficiency and lymphoproliferative disorders.
    Gupta S; Good RA; Siegal FP
    Clin Exp Immunol; 1976 Nov; 26(2):204-13. PubMed ID: 1068759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active rosette test in cutaneous lymphoproliferative disorders.
    Bernengo MG; Capella G; Mascoli I; Zina G
    Dermatologica; 1977; 154(6):342-9. PubMed ID: 328325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymus-dependent lymphocytes in lymphoproliferative disorders of the skin (Sézary syndrome and mycosis fungoides).
    Zucker-Franklin D
    J Invest Dermatol; 1976 Sep; 67(3):412-8. PubMed ID: 135031
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppressor T cells in mycosis fungoides and so-called premycotic eruptions.
    Wassermann J; Biberfeld G; Baral E; Blomgren H; Thyresson N; Brehmer-Andersson E
    Acta Derm Venereol; 1980; 60(2):139-43. PubMed ID: 6155020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-rosette inhibitory factor in sera from patients with mycosis fungoides.
    Yambe H; Ishii Y; Kikuchi K; Jimbow K
    J Invest Dermatol; 1981 May; 76(5):376-80. PubMed ID: 6971906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--part II.
    Safai B
    Clin Bull; 1977; 7(4):140-5. PubMed ID: 147147
    [No Abstract]   [Full Text] [Related]  

  • 16. Human lymphocyte subpopulations defined by double surface markers.
    Bankhurst AD; Hastain E; Husby G; Diaz-Jouanen E; Williams RC
    J Lab Clin Med; 1978 Jan; 91(1):15-23. PubMed ID: 304082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte transformation in patients with staged mycosis fungoides and Sézary syndrome.
    du Vivier A; Harper RA; Vonderheid E; Van Scott EJ
    Cancer; 1978 Jul; 42(1):209-13. PubMed ID: 149588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subpopulations of human T lymphocytes. IV. Quantitation and distribution in patients with mycosis fungoides and Sézary syndrome.
    Gupta S; Safai B; Good RA
    Cell Immunol; 1978 Aug; 39(1):18-26. PubMed ID: 308846
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of functional immunoregulatory cells in a patient with mycosis fungoides and circulating Sézary cells.
    Kermani-Arab V; Roberts JL; Hanifin JM; Leslie GA
    J Natl Cancer Inst; 1978 Jun; 60(6):1295-9. PubMed ID: 148516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for activated C3 on thymus-dependent (T) lymphocytes of normal guinea-pigs.
    Wilson AB; Prichard-Thomas S; Coombs RR
    Immunology; 1979 Jun; 37(2):377-84. PubMed ID: 112046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.